Let's Vaccinate, CNMI!

We have successfully begun administering the COVID-19 vaccine to people in phase 1a and portion of 1b of the CNMI COVID-19 Vaccination Plan. Since December 19, 2020 we’ve initiated COVID-19 vaccination for 3,100 people living in the CNMI.

Special thanks to our wonderful partners for their continued support and assistance:

Public Assistance Office, CNMI Homeland Security and Emergency Management Office, Department of Public Safety, Department of Fire and Emergency Management Services, Kagman Community Health Center.

Vaccination dates are limited. Vaccination openings are capped per vaccination day.

For more information please contact us at:
CNMI COVID-19 VACCINATION CALL CENTER: (670) 682-SHOT (7468) / 7am-10pm Daily

Operations Calendar

SAIPAN
Saturday (01/23)
Dose 1: Phase 1a & 1b 

Sunday (01/24)
UNAVAILABLE

Monday (01/25) 
Dose 1: 358 doses available for Phase 1a & 1b
Dose 2: 42 doses for 01/04/2021

Tuesday (01/26) 
Dose 1: 400 doses available for Phase 1a & 1b

Wednesday (01/27)
Dose 1: 400 doses available for Phase 1a & 1b

Thursday (01/28)
Dose 1: 400 doses available for Phase 1a & 1b

Friday (01/29) 
Dose 1: 400 doses available for Phase 1a & 1b

Saturday (01/30)
Dose 1: 307 doses available for Phase 1a & 1b
Dose 2: 93 doses for 01/09/21


ROTA
SUNDAY (01/24/21)
-DOSE 1: Phase 1a

*PLEASE REGISTER ONLINE OR OVER THE PHONE (670) 682-7468

Vaccination Site Information

SAIPAN
Time of Operations: 8AM to 3PM (Closed on Sunday 01/24/21)
Location: CHCC – MCATS Tents across from Emergency Room.
Parking: Across the CHCC campus on Navy Hill Road.

TINIAN 
Time of Operations: TBD
Location: Tinian Health Center

ROTA
(Sunday, January 24th, 2021)
Time of Operations: 10am-3pm
Location: Rota Health Center

Requirements

Please bring the following to your appointment:
1. Vaccination ID – Found in confirmation email after registration
2. Valid Government Issued ID (e.g, driver’s license or passport)
3. Insurance Card – If applicable. Vaccine is FREE of charge.

What is the Coronavirus

Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus called SARS-CoV-2.

The COVID-19 virus spreads mainly between people who are in close contact with one another (within 6 ft), primarily through respiratory droplets produced when an infected person coughs or sneezes.

Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Older people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness.

COVID-19 Vaccine (FAQs)

Many people are anticipating the arrival of a vaccine for COVID-19. Details are still being determined. Below is what we currently know about COVID-19 vaccines.

Vaccine Availability

Our goal is to make COVID-19 vaccination available to everyone living in the CNMI who chooses to receive it. Our CNMI approach prioritizes population groups that are at increased risk for getting COVID-19 and severe COVID-19 illness.

Each group will become eligible for the vaccine one at a time based on completion of the previous phase and will continue to be eligible throughout the vaccine distribution. Our timelines plans are continually being updated and adapted as more information becomes available.

Man Amko’ (people 65 years and older) are at increased risk for severe COVID-19 illness. Severe illness means that the person with COVID-19 may require hospitalization, intensive care, or a ventilator to help them breathe, or that they may even die. We encourage Man Amko’ to talk to their doctor or healthcare provider about COVID-19 vaccination, especially if they also have underlying health conditions. Early vaccine access is critical to ensuring the health and safety of this population.

How CDC Is Making COVID-19 Vaccine Recommendations

CNMI wants to ensure the vaccines are accessible to everyone in the CNMI, however, rolling out the vaccines requires consideration of many factors. Having phases ensures that individuals in specific groups have equitable access to the available vaccines. Currently, we are engaging people working in high-risk healthcare and first-responders settings as they are in direct physical contact or line of work with persons exposed or potentially exposed to COVID-19.

Estimated timelines for CNMI COVID-19 Vaccination by Phase

    • Phase 1a: People working in high risk healthcare and first responders settings, Man Amko’ (people 65 years and older), and homebound/bed bound patients.

    • Phase 1b: Persons 55 years or older and workers part of CNMI infrastructure (listed on CISA Sector Graphic) across public and private sectors:

      a) Media & Telecommunications

      • For example: Docomo Pacific, IT&E, KSPN, Marianas Variety, Saipan Tribune, KKMP, Magic100.3, Power99 (List is not all inclusive of all public or private entities under this group)

         

      b) Food & Agriculture – Grocery store workers, Restaurant/Catering/Bakery workers, and Wholesalers

      • For example: Marianas Pacific Distributors, Pacific Trading Company, Western Trading Company, D&Q, Triple J, Joeten Grocery Stores & Delis, Luen Fueng, Yaong, and XO (List is not all inclusive of all public or private entities under this group)

         

      c) Transportation Systems

      • For Example:  Postal Services, Triple B, COTA, Tasi Tours, Saipan Stevedore, Cargo Express, CTSI Logistics, CNMI Global Logistic, DHL, Micronesian Brokers, Royal Pacific Express, LBC Express, Car rental, and Car repair (List is not all inclusive of all public or private entities under this group)

         

      d) Commercial Facilities (List is not all inclusive of all public or private entities under this group)

      • Entertainment and Media (e.g., motion picture studios, broadcast media).
      • Gaming (e.g., casinos).
      • Lodging (e.g., hotels, motels, conference centers).
      • Outdoor Events (e.g., theme and amusement parks, fairs, campgrounds, parades).
      • Public Assembly (e.g., arenas, stadiums, aquariums, zoos, museums, convention centers).
      • Real Estate (e.g., office and apartment buildings, condominiums, mixed use facilities, self-storage).
      • Retail (e.g., retail centers and districts, shopping malls).
      • Sports Leagues (e.g., professional sports leagues and federations).


      e) Energy and Utilities – Commonwealth Utilities Corporation
      f) Financial Services – Bank of Hawaii, Bank of Guam, First Hawaiian
      g) Bank, Bank of Saipan
      Waste & Water Systems – CNMI Transfer
      h) Station, AYD, Artman, Saipan Water & Ice, S.T.A.R. Water
      i) Education (Staff) – PSS, NMC, Private Schools, and Daycares.
      j) Faith-Based Leaders
      k) Covid-19 Contractors employed by the CNMI Governor’s Task Force.
      l) CNMI (State/Local) Government Employees (All agencies)

    • Phase 2: Other Essential Workers across sectors and people with high-risk medical conditions.

    • Phase 3: The CHCC will begin to make COVID-19 vaccination available to the general population.

The ACIP’s Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine

CHCC has received two COVID-19 vaccines. The vaccines are proven to be 90% effective however, in comparison to the Pfizer-BioNTech COVID-19 Vaccine ultra-cold, the Moderna COVID-19 Vaccine is being shipped in smaller quantities and can be stored in most standard medical freezers.

These characteristics allows us broaden CNMI COVID-19 Vaccination effort. Specifically, at this time the CNMI Health Official has determined the priority use of this initial limited supply of Moderna COVID-19 Vaccine for the following target populations:
1) Homebound/bedbound population
2) Residents of Tinian
3) Residents of Rota

Once we have successfully vaccinated these populations, we will reassess our vaccination strategy to expand use of Moderna COVID-19 Vaccine to other populations and to assess coordination with private providers in the CNMI to become pre-approved vaccination locations.

Benefits of COVID-19 Vaccination

    • Based on what we know about vaccines for other diseases and early data from clinical trials, experts believe that getting a COVID-19 vaccine may also help keep you from getting seriously ill even if you do get COVID-19.

    • COVID-19 vaccination is a safer way to help build protection. COVID-19 vaccination will help protect you by creating an antibody (immune system) response without having to experience sickness.

    • COVID-19 vaccination will be an important tool to help stop the pandemic. Wearing masks and social distancing help reduce your chance of being exposed to the virus or spreading it to others, but these measures are not enough. Vaccines will work with your immune system so it will be ready to fight the virus if you are exposed.

We encourage everyone interested in getting the COVID-19 vaccine to talk to their doctor or healthcare provider before vaccination.

Vaccine Safety

Pfizer’s vaccine has been authorized for ages 16 and up. Moderna’s vaccine is currently authorized for ages 18 and up. Both companies have begun clinical trials for younger kids.

Administering a safe and effective vaccine is our top priority. We will rely on guidance provided by the Centers for Disease Control and Prevention (CDC) based on the Food and Drug Administration (FDA) before we consider administering the COVID-19 vaccine in the CNMI. All COVID-19 vaccines were tested in clinical trials involving tens of thousands of people to make sure they meet safety standards and protect adults of different ages, races, and ethnicities. There were no serious safety concerns. CDC and the FDA will keep monitoring the vaccines to look for safety issues after they are authorized and in use. Tell Me More About Vaccines

Currently authorized vaccines, and most vaccines under development, require two doses (shots). The first shot helps the immune system recognize the virus, and the second shot strengthens the immune response. You need both to get the best protection.

The two vaccines authorized and recommended to prevent COVID-19 are Pfizer-BioNTech COVID-19 vaccine and Moderna’s COVID-19 have now shown remarkable effectiveness of abouot 95% in preventing COVID-19 infection in adults. As the first round of vaccine recipients become eligible to receive their second dose, we want to remind the public about the importance of receiving COVID-19 vaccines according to how they’ve been authorized by the FDA in order to safely receive the level of protection observed in the large randomized trials supporting their effectiveness.

The CHCC’s vaccination effort is informed by the available data and continues to support use of two specified doses of each authorized vaccine at specified intervals. For the Pfizer-BioNTech COVID-19 vaccine, the interval is 21 days between the first and second dose. And for the Moderna COVID-19 vaccine, the interval is 28 days between the first and second dose.

Yes. If you receive a vaccine product that requires two doses, the second dose must be the same brand/manufacturer as the first dose.

There may be side effects, but they should go away within a couple of days. Possible side effects include a sore arm, headache, fever, or body aches. This does not mean you have COVID-19. Side effects are signs that the vaccine is working to build immunity. If they don’t go away in a week, or you have more serious symptoms, call the CHCC Tele-Triage 24/7 Hotline at (670) 233-2067

Common side effects from vaccination include pain, swelling or redness where the shot was given, a mild fever, chills, fatigue, headache, and muscle and joint aches. These side effects were also noted in COVID-19 vaccine clinical trials.

Because all COVID-19 vaccines are new, it will take more time and more people getting vaccinated to learn about very rare or possible long-term side effects. The good news is, at least 8 weeks’ worth of safety data were gathered in the clinical trials for all the authorized vaccines, and it’s unusual for vaccine side effects to appear more than 8 weeks after vaccination.

There may be side effects, but they should go away within a couple of days. This does not mean you have COVID-19.
    • Sign-up for V-Safe at vsafe.cdc.gov it is a smartphone-based tool that checks in on you after your COVID-19 vaccination.
    • Call the Vaccinate CNMI Call Center at (670) 682-7468 (SHOT)
    • If your symptoms don’t go away in a week, or you have more serious side effects please call the CHCC Tele-Triage Hotline available 24hrs a day at: (670) 233-2067
If you are experiencing life-threatening symptoms such as chest pain, severe headache followed by confusion and blurred vision, nausea and vomiting, severe anxiety, shortness of breath or seizures please call 911 immediately.
    • The COVID-19 vaccine will not be given to individuals with a known history of a severe allergic reaction (e.g. anaphylaxis) to a previous dose or any component of a COVID-19 vaccine.

    • It is not recommended to get any vaccines around the same time as the COVID-19 vaccines. If you were recently vaccinated, including the influenza (flu), you should wait a minimum of 2 weeks before getting either of the COVID-19 vaccines.

    • Individuals who are not able to go to their dose 2 appointment will not get their dose 1.

    • Once you get dose 1 of the vaccine series you will automatically be scheduled for dose 2.

    • Keeping your dose 2 appointment is important in ensuring maximum vaccine protection.

    • We are not rescheduling patients who are unable to make their dose 2 appointment at this time.

    • Those younger than 16 years of age

    • People currently isolating or experiencing symptoms of COVID-19; these people can get vaccinated once they are finished isolation and their primary symptoms have resolved.

Yes! The CDC recommends that you get vaccinated even if you have already had COVID-19, because you can catch it more than once. While you may have some short-term antibody protection after recovering from COVID-19, we don’t know how long this protection will last.

Yes. Pregnant women may choose to be vaccinated. Since pregnant women are at increased risk for severe illness from COVID-19, they should weigh the risk of COVID-19 (i.e.healthcare workers) with the risks of vaccination. We encourage everyone, especially pregnant women, to discuss vaccination with their doctor or healthcare provider.

COVID-19 vaccines have not yet been tested in pregnant women. The Moderna and Pfizer vaccines were tested in ~37,000 people, and there were no serious side effects. However, these vaccines were not tested in pregnant women. Some women did become pregnant during the study. No adverse events in the vaccinated pregnant women have been reported.

The American College of Obstetricians & Gynecologists (ACOG) recommends: “COVID-19 vaccines should not be withheld from pregnant individuals who meet criteria for vaccination based on ACIP recommended priority groups.”

Guidance from The American College of Obstetrics and Gynecology https://www.acog.org/en/clinical/clinical-guidance/practice-advisory/articles/2020/12/vaccinating-Pregnant-and-Lactating-Patients-Against-COVID-19

The Society for Maternal-Fetal Medicine strongly recommends that pregnant individuals have access to COVID-19 vaccines. They recommend that each person have discussion with their healthcare professional about their own personal choice.

Pregnant women who experience a fever following vaccination should be counseled to take acetaminophen, as fever has been associated with adverse pregnancy outcomes.

Yes. People with common allergies can receive the COVID-19 vaccine. The COVID-19 vaccine will not be given to individuals with a known history of a severe allergic reaction (e.g. anaphylaxis) to a previous dose or any component of a COVID-19 vaccine. It is still important to let your healthcare provider know about any latex allergies so they can ensure they do not use any latex containing products (ex. gloves) when administering the vaccine.

Getting Vaccinated

As COVID-19 vaccines are authorized and then recommended for use in the United States, it will be important to understand what is known about each vaccine. 

Currently, two vaccines are authorized and recommended to prevent COVID-19:

If you receive a vaccine product that requires two doses, the second dose must be the same brand/manufacturer as the first dose.

The COVID-19 vaccine is being provided to us through the U.S. Government. The vaccines will be available at no cost to everyone living in the CNMI who chooses to receive it.CHCC will attempt to bill insurance companies to cover the cost of vaccine administration. This is why insurance information is part of our registration process.

Depending on vaccination phase implementation, appointment registration for dose 1 COVID-19 vaccination is available:

1/9/2021-1/10/2021 8AM to 4PM (registration closes at 3PM)

    • On-site Registration at CHCC MCATS Vaccination Tents is available for Man Amko’ (65 years and older)
    • On-site registration does not guarantee same day vaccination
    • Parking is located across the CHCC campus on Navy Hill Road

You will need a Valid Government Issued ID (driver’s license or passport) and your insurance information (not required). People who register online will be promoted to upload a copy of their Valid Government Issued ID. If you are unable to upload an ID, call the Vaccinate CNMI Call Center for further assistance.

Bring a valid government issued ID (driver’s license or passport; international passports will be accepted) and your COVID-19 Vaccination ID. 

Please call the Vaccinate CNMI Call Center if you are unable to go to your dose 1 appointment. Rescheduling of dose 1 appointments are based upon available dates and spots.

We are doing our best to provide vaccination for everyone in the CNMI. Expect to be at your appointment for at least 45 minutes.

    • Stage 1 Verification: Have a valid driver’s license or passport and insurance card on hand

    • Stage 2 Vaccination: Receive your COVID-19 vaccine

    • Stage 3 Observation: Be monitored by healthcare staff for 15-30 minutes for any immediate side effects and get your COVID-19 vaccination record card for your next appointment!

After Vaccination

Yes. The CHCC and CDC recommend that during the pandemic people wear a mask that covers their nose and mouth when in contact with others outside your household, when in healthcare facilities, and when receiving any vaccine, including a COVID-19 vaccine. While we are still in a pandemic, continue practicing the 3W’s: Wear a Mask, Watch your Distance, and Wash your hands!

Alcohol suppresses the immune system, so it would be advisable not to drink alcoholic beverages 24 hours after getting vaccinated. Moderate consumption of alcohol is always recommended, if people do choose to drink.

Some countries require proof of vaccination for certain diseases like yellow fever. It’s important to plan ahead to get the shots required for all countries you and your family plan to visit. At this time, it is unknown if getting the COVID-19 vaccine will be a requirement for travel. However, if you are planning to get your COVID-19 vaccine, please ensure that you are able to go to your dose 1 and dose 2 appointments (either 21 or 28 days apart) for maximum protection. We are not rescheduling patients who are unable to make their second appointment at this time. Getting the COVID-19 vaccines does not guarantee that you will be exempt from quarantine or other travel requirements. 

For more information about shots required for all countries visit https://wwwnc.cdc.gov/travel/destinations/list/

People traveling are not being prioritized to receive the COVID-19 vaccine. Traveling should not be a motivator for receiving the vaccine.  

While the vaccines appear to be highly effective at preventing disease, it might not prevent asymptomatic infection, meaning vaccine recipients might still be able to get infected, but not have symptoms and, therefore, unknowingly spread the virus. Vaccine manufacturers will be doing additional studies to better understand whether this is the case.

Every COVID-19 vaccine dose counts. Please ensure that you are able to go to your dose 1 and dose 2 appointments (either 21 or 28 days apart).  Once you get dose 1 of the vaccine series you will automatically be scheduled for dose 2. We are not rescheduling patients who are unable to make their dose 2 appointment at this time.

Yes. We encourage people taking medication or antibiotics to talk to their doctor or healthcare provider before getting the vaccines.

There may be side effects, but they should go away within a couple of days. This does not mean you have COVID-19.

    • Sign-up for V-Safe at vsafe.cdc.gov it is a smartphone-based tool that checks in on you after your COVID-19 vaccination.

    • Call the Vaccinate CNMI Call Center at (670) 682-7468 (SHOT)

    • If your symptoms don’t go away in a week, or you have more serious side effects please call the CHCC Tele-Triage Hotline available 24hrs a day at: (670) 233-2067

If you are experiencing life-threatening symptoms such as chest pain, severe headache followed by confusion and blurred vision, nausea and vomiting, severe anxiety, shortness of breath or seizures please call 911 immediately.

COVID-19 Facts

What you can do now to help protect yourself from getting COVID-19 since a vaccine is not available at this time.

Continue to help slow the spread of COVID-19: Wear a mask, wash your hands often, stay 6 feet away from other people, and stay home if you are sick. The more steps you and your family can take to prevent the spread of COVID-19, the safer you will be.

You can also get a flu vaccine. Flu vaccines save lives and prevent more flu during the COVID-19 pandemic. People need to do everything they can to stay healthy and not overwhelm our health care system this flu season.

Flu vaccines are available at your primary care provider, CHCC, Tinian Health Center, and Rota Health Center.

COVID-19 Vaccine (FAQs)

Many people are anticipating the arrival of a vaccine for COVID-19. Details are still being determined. Below is what we currently know about COVID-19 vaccines.

As the lead health subject matter expert (SME), the Commonwealth Healthcare Corporation is leading the COVID-19 vaccine planning for the CNMI. This effort includes representatives from the Governor’s COVID-19 Taskforce. Our planning is coordinated with regional and national SMEs with several agencies and offices within the US Department of Health and Human Services (HHS), including but not limited to the Assistant Secretary for Preparedness and Response, Assistant Secretary for Health, and the Centers for Disease Control and Prevention.

The COVID-19 Pfizer-BioNTech vaccines (authorized by the FDA for emergency use) arrived in the CNMI by United Airlines on 12/17/2020 and was securely transported to CHCC for refrigeration. The Emergency Use Authorization (EUA) allowed the Pfizer-BioNTech COVID-19 vaccine to be distributed to every U.S. state and territory. Operation Warp Speed began vaccine distribution immediately after its EUA approval. The Pfizer-BioNTech COVID-19 vaccines are being stored in an ultra-low temperature freezer (-60°C to -80°C). Those in healthcare who are at a high risk of exposure are expected to start receiving their first vaccine doses as early as Saturday 12/19/2020.

CNMI Interim COVID-19 Vaccination Plan Executive Summary

Last Updated on: 12/17/2020 

Administering a safe and effective vaccine is our top priority. We will rely on guidance provided by the Centers for Disease Control and Prevention (CDC) based on the Food and Drug Administration (FDA) before we consider administering the COVID-19 vaccine in the CNMI:

      1. The FDA determines that a vaccine meets its safety and effectiveness standards, it can make these vaccines available for use in the United States by approval or emergency use authorization (EUA).

      2. After the FDA makes its determination, the Advisory Committee on Immunization Practices (ACIP) will review available data before making vaccine recommendations to CDC.

      3. The CDC Advisory Committee on Immunization Practices and other groups look at available information about a vaccine and make informed decisions about the risks and benefits of using it.

The CHCC will make the COVID-19 vaccines available to people working in healthcare settings as they are responsible for providing care and dealing directly with patients who may have COVID-19. This effort will engage both private and public healthcare providers to ensure all healthcare workers in the CNMI are protected as they continue to provide care to the sick and ailing.

The CHCC will also engage First Responders on a tiered approach, giving priority to those directly involved in the CNMI’s continued preparedness and response efforts to combat COVID-19. Essential workers and vulnerable populations will also begin to be prioritized to receive the COVID-19 vaccine

As stated in our plan, we will be implementing a 3-phased approach:

Phase 1 – People working in healthcare settings, first responder agencies, essential workers, and vulnerable populations

Phase 2 – Remainder of Phase 1 and initiation of the general population

The COVID-19 vaccine will continue to be offered to essential workers and people living with underlying health conditions. The CHCC will begin to make COVID-19 vaccine available to the general population.

Phase 3 – Remainder of Phase 2

Our overall goal is to have the COVID-19 vaccine available to everyone living in the CNMI. We are hoping to have 95% of the CNMI population to have received the COVID-19 vaccine in 2021.

Our overall goal is to have the COVID-19 vaccine available to everyone living in the CNMI. We are hoping to have 95% of the CNMI population to have received the COVID-19 vaccine in 2021.

In the CNMI there are about 1,600 people working in healthcare settings and first responder agencies. We are currently in conversation with these agencies about assisting with the CNMI COVID-19 vaccine initiative. Scheduling these individuals to receive the COVID-19 vaccine is again based on when the EUA submissions take place.

The COVID-19 vaccine is being provided to us by the U.S. Government. It will be available free of charge to all people living in the CNMI.

At this time, we are anticipating to receive COVID-19 vaccines that need 2 shots to be effective.

Yes! We are working in collaboration with the Governor’s COVID-19 Task Force and other partner agencies to procure other storage solutions for other anticipated vaccines that we might receive.

There are many tests, clinical trials, and data being collected in the U.S. mainland to fulfill the EUA process. Again, administering a safe and effective vaccine is our top priority. We are looking at guidance provided by the CDC and monitoring the vaccine safety data that is available to the public before considering COVID-19 vaccine administration in the CNMI.

Currently, the CHCC is not conducting community based testing.

Individuals who require a diagnostic test for SARS-CoV-2 for travel outside the CNMI, will need to make an appointment 2 days prior to departure date. Testing costs $300 and results will be available in 24 hours after specimen collection.

Saipan (Family Care Clinic) 

Monday – Friday 7:30 AM – 4:30 PM 

Phone: 670-234-8951 ext. 3303 or 670-285-1542 

*By appointment only 

COVID-19 testing is also available in Tinian and Rota. Information can be found in the Contact page.

Symptoms may appear 2-14 days after exposure to the virus. People with these symptoms may have COVID-19:

      • Fever or chills
      • Cough
      • Shortness of breath or difficulty breathing
      • Fatigue
      • Muscle or body aches
      • Headache
      • New loss of taste or smell
      • Sore throat
      • Congestion or runny nose
      • Nausea or vomiting
      • Diarrhea

If you are experiencing one or more symptoms of COVID-19, call the Tele-Triage Hotline at 670-233-2067 or contact your personal healthcare provider. A medical provider or the local health department will perform a proper diagnosis and decide if a viral test for COVID-19 is needed.

Resources

Skip to content